[China Eastern Airlines Corporation Limited Date February 5, 2018 By Wang Jian Company Secretary This announcement is for information purposes only and does not constitute an invitation or offer to acquire, purchase or subscribe for securities or an invitation to enter into any agreement to do any su]
[Number Page 1.1 Voluntary Disclosure, dated February 1, 2018 A-1 • our business objectives and strategies, including those relating to the development of our terminal procurement and distribution business; • our operations and prospects; • our network expansion and capital expenditure plans; • the e]
[EXECUTION VERSION AMENDMENT TO SHARE AND ASSET PURCHASE AGREEMENT Amendment THIS AMENDMENT TO THE SHARE AND ASSET PURCHASE AGREEMENT (this 浙江蚂蚁小微金融服务集团 股份 有限公司 浙江蚂蚁小微金融服务集团有限公司 浙江淘宝网 络 有限公司 杭州阿里 创业 投 资 有限公司 支付宝 中国 网络技术有限公司 杭州君澳股 权 投 资 合伙企 有限合伙 杭州君瀚股权投资合伙企业 有限合伙 Parties RECITALS WHEREAS, the Partie]
[The9 Singapore and a Solar Energy Company Signed a Partnership Agreement to Cooperate in Distribution of Solar Energy Using Blockchain Technology Shanghai, China, February 1, 2018 one-stop C&I is a joint venture company established in Singapore by Comtec Solar Systems Group Limited (HKSE: 00712) and]
[FORM 6-K Aluminum Corporation of China Limited People's Republic of China 100082 No. 62 North Xizhimen Street X Form 20-F X Yes 99.1 MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES Aluminum Corporation of China Limited Date February 2, 2018 By]
[Number 1 Announcement dated February 1, 2018 in respect of Voluntary Disclosure Commercial Pricing of the Lease of Telecommunications Towers and Related Assets From China Tower Corporation Limited. build-out the Companys ability to effectively sustain its growth and to achieve or enhance profit]
[13G CUSIP No.: 874080104 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON VANGUARD WORLD FUNDS - VANGUARD INTERNATIONAL GROWTH FUND - 23-2471346 2. CHECK THE APPROPRIATE [LINE] IF A MEMBER OF A GROUP A. B. X 3. SEC USE ONLY 4. CITIZENSHIP OF PLACE OF ORGANIZATION Delawar]
[Our ref.: PS/SC/B397/AUD3/pp February 2, 2018 100F Street NE Washington DC Dear Sirs, We have read Item 4.0l (a) of Biostar Pharmaceuticals, Inc's Form 8-K, which discusses the resignation of Mazars CPA Limited as its independent registered public accounting firm, and we agree with the statements ma]
[______________ FORM 8-K ______________ CURRENT REPORT Date of Report (Date of earliest event reported): January 29, 2018 ______________ BIOSTAR PHARMACEUTICALS, INC. ______________ Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identificatio]
